← FDA Drug Approvals (Drugs@FDA)

TYGACIL

NDA · New Drug Application · Sponsor: PF PRISM CV · Approved 2005-06-15

Drug application

FDA Application #

NDA021821

Application type

New Drug Application

Brand name

TYGACIL

Generic name

TIGECYCLINE

Active ingredients

TIGECYCLINE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

PF PRISM CV

Manufacturer

Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.

First approval

2005-06-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown